Cassidy, McCaskill Introduce Transparency Legislation Targeting Opioid Manufacturers' Payments to Advocacy Groups
October 11, 2018
October 11, 2018
WASHINGTON, Oct. 11 -- The office of Sen. Bill Cassidy, R-Louisiana, issued the following news release:
U.S. Senators Bill Cassidy, M.D. (R-LA), and Claire McCaskill (D-MO) today introduced the Opioid Advocacy Transparency Act, bipartisan legislation requiring opioid manufacturers to disclose payments made to patient and consumer organizations involved in opioid-related advocacy--similar to existing disclosure requirements governing payments to physicians.
The senators' . . .
U.S. Senators Bill Cassidy, M.D. (R-LA), and Claire McCaskill (D-MO) today introduced the Opioid Advocacy Transparency Act, bipartisan legislation requiring opioid manufacturers to disclose payments made to patient and consumer organizations involved in opioid-related advocacy--similar to existing disclosure requirements governing payments to physicians.
The senators' . . .